
|Videos|April 23, 2018
Forecasting PARP Inhibitor Resistance in Breast Cancer Patients
Author(s)Elizabeth Swisher, MD
In this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in breast cancer, and the importance of understanding how resistance to these agents develops.
Advertisement
In this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in ovarian cancer, and the importance of understanding how resistance to these agents develops.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Modifiable Risk Factors Suggest Potential for Improving Cancer Prevention
2
Exploring The Impact of ADTs on Cardiac Risk in Prostate Cancer Treatment
3
Barriers to CAR T-Cell Referral and Center Access in Multiple Myeloma
4
2026 Tandem Meetings: Whatโs the Latest Research in Multiple Myeloma?
5



































